CMG vs MBRX · P/E 50, rev $3.35B vs $8.2M cap
Chipotle Mexican Grill Inc (CMG) versus Moleculin Biotech Inc (MBRX) — a side-by-side from cached financials, not a winner call.
Chipotle Mexican Grill Inc (CMG) is a restaurants company listed on US.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
Latest reported CMG revenue for 2026-06-30 was $3.35B. Net income was $403.5M. Revenue was up 8.4% from 2026-03-31 to 2026-06-30. CMG currently screens at market cap $76.00B and trailing P/E 50.0.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
CMG currently screens at market cap $76.00B and trailing P/E 50.0. MBRX currently screens at market cap $8.2M.
Not investment advice. Open the CMG and MBRX stock pages for the full models.
Not investment advice.